The report Global Blue Biotechnology Market covers the analysis and forecast of the blue biotechnology market on global as well as regional level, provides historic data of 2016 along with the forecast for the period between 2017 and 2025.
The study provides a detailed view of the blue biotechnology market, by segmenting it based on by product type, by application, by end- user and regional demand. Robust growth of drug discovery in the past several years propels the growth for the blue biotechnologys market. Growing usage of algae along with other bacteria for producing a new drug is another prime factor driving the market demand. Extensive use of blue biotechnologys in end-user industries such as pharmaceutical, research organization, healthcare, and others boosts the demand of this market.
Leading Market Players of Global blue biotechnology market:
Aker Biomarine
Cellgen Biologicals Pvt Ltd.
Donald Danforth Plant Science Center
Geomarine Biotechnologies
Glycomar
Marinova
Nurture Aqua Technology Pvt.
New England Biolabs
Pices
Pml Application Ltd.
Global blue biotechnology market has been segmented into:
By Product Type
Pharma
Biofuels
Food
Enzymes
Biopolymers
By Application
Vaccine development
Drug finding
Genomics
By End- User
Pharmaceutical companies
Biotechnology companies
Research organization
Healthcare centre
By Regions:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Rest of Latin America
About Aarkstore Enterprise
Aarkstore curates global market research reports from various industry verticals and serves businesses worldwide. As market research report resellers, we at Aarkstore, partner with established publishers for both; syndicated data and customized reports. The market research data supplied by us is up-to-date and reliable for current day industry analysis and future market forecasts equally.
Avail market research reports from us and gathers critical information about customer preferences, market requirements, key drivers and challenges for your business to align your strategies with them. The comprehensive overview of the market provided will allow you to make insight-driven decisions giving you an upper hand in the competitive landscape.
Category: Healthcare Market Research
Aarkstore Enterprise
+91 9987295242 | [email protected] | aarkstore.com
This report aims to provide detailed insights into the NGS-based RNA-sequencing market.
It provides valuable information on the type, procedure, application, and region in the market.
Expected Revenue Growth: The NGS-based RNA-sequencing industry size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816 Key Factors Driving Market Growth: Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.
The expression profiling analysis segment accounted for the largest share of the NGS-based RNA-sequencing industry, by application, in 2018 Based on application, the NGS-Based RNA-Sequencing Market is segmented into expression profiling analysis, small RNA sequencing, De Novo transcriptome assembly, and variant calling & transcriptome epigenetics.
Nanopore sequencing technology registers the highest growth rate in the market as it is the only sequencing technology with direct RNA sequencing capabilities and facilitates sequencing of full-length RNA strands and modified RNA nucleotides using a simple library prep, without the need of conversion to double-stranded DNA.
According to the new market research report “Single-Use Assemblies Market by Product (Bag Assembly, Filtration Assembly, Bottle Assembly, Mixing Assembly), Application (Filtration, Storage), Solution (Standard, Customized), End User (Pharmaceutical Companies, CMOs and CROs) – Global Forecast to 2024” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?The single-use assemblies market is projected to reach USD 1,825 million in 2024 from USD 805 million in 2019, at CAGR of 16.5% during the forecast periodGrowth Boosting Factors:– Rapid Implementation and Low Risk of CROs s-Contamination– Increasing Biopharmaceutical R– Emerging CountriesBrowse 102 Market Data Tables and 33 Figures spread through 148 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46226549Leading Key Players in the Worldwide Industry:The major companies in the single-use assemblies market include Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher (US), Merck Millipore (Germany)), and GE Healthcare (US).Sartorius Stedim Biotech (France) is the most significant player in the global market.
The company has an expansive range of single-use assemblies products.
The growth of revenue strongly backed up by demand from the Americas and APAC countries and efforts of the company to meet the differentiated needs of consumers from emerging Asian markets.
The company launched two single-use filter assemblies products in the past three years, including such as Sartocon Self-contained Filter Loop Assembly and Sartocon Slice Self-contained Bag Loop Assembly.
The company also focuses on inorganic growth strategies such as partnership, collaboration, and acquisitions to strengthen its position in the market.Geographical Regions Mapped in Report:The single-use assemblies market is divided into four major regions-Europe, North America, Asia Pacific, and the Rest of the World (RoW).
In 2018, North America accounted for the largest share of the global market, closely followed by Europe.
Market Synopsis:Blue biotechnology deals with the application of biotechnology to marine or aquatic sources at a molecular level to extract active new ingredients for development of new drugs and other purposes.
Market Research Future (MRFR) has published a report asserting that the global blue biotechnology market is anticipated to expand at a strong CAGR of 10.2% during the forecast period of 2017-2023.
Global Blue Biotechnology Market To Project Significant Expansion At A CAGR of 10.2% During 2017-2023Request Sample Copy:https://www.marketresearchfuture.com/sample_request/713Market Driver and Restraints:Oceans and Seas consist of large biodiversity and the development in the field of biotechnology has made it possible to utilize the marine and aquatic sources for obtaining various products that are useful for mankind.
The availability of large market for blue biotech products in the various sectors is majorly driving the global blue biotechnology market.The increasing demand for blue biotech products in the pharmaceutical industry for production of various medicines and drugs is fueling the expansion of the global blue biotechnology market.
The flexibility, adaptivity and constant development of blue biotechnology are widening its application range in various industries.Market Segmentation:The global blue biotechnology market has been segmented on the basis of product, application and end-users.
Based on end-users, the blue biotechnology market is segmented into hospitals, pharmaceutical companies, biotechnology companies, research institutes, laboratories, and others.
Global Blue Biotechnology market, by Product (Enzymes, Pharma Products, Bulk Chemicals, Biopolymers), by Application (Bio-Engineering, Genomics, Vaccine Development, Drug Discovery, Others), by End-Users (Hospitals, Labs) – Forecast Till 2027The global market consist of players such as Aker BioMarine (Norway), Marinova (Australia), New England Biolabs (U.S), PML Applications Ltd. (U.K), Sea Run Holdings, Inc.(U.S), PICES (Canada), Donald Danforth Plant Science Center (U.S), GeoMarine Biotechnologies (India), GlycoMar (Scotland), Cellgen Biologicals Pvt Ltd. (India), Nurture Aqua Technology Pvt.
These are some of the prominent players at the forefront of competition in the global blue biotechnology market.Global Blue Biotechnology Market - OverviewBlue biotechnology provides numerous advantages like use of marine organisms in the field of biotechnology by modifying their genome, and diagnosis of diseases through microbial testing which contributes to the growth of this market.
Some of the examples of marine-derived drugs include an antibiotic from a fungi, two closely related compounds extracted from a sponge that can be used to treat cancer and the herpes virus, and a neurotoxin from a snail that has a kind of painkiller properties which makes it 10,000 times more potent than morphine without having any side effects to the patient.
Moreover, there are several more marine-derived compounds currently in clinical trials and it is likely that many more of such will advance to the clinic as more scientists are looking to the ocean for these biotechnological uses.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/713According to a recent study published by the Market Research Future analysts, the global blue biotechnology Market is growing at a double digit growth rate; mainly due to increasing demand of marine biotechnology products, increasing application of marine biotechnology in healthcare and extensive research and development activities.
Later the applications of GFP in neuroscience unfolded.In 2005, The Irish Elan cooperation brought a synthetic version of the drug Ziconotide on the European markets in 2005 under the brand name Prialt.
The drug is intended for use by patients suffering from intense and prolonged pain caused by e.g.
The report covers the analysis and forecast of the drug delivery devices market on global as well as regional level,provides the size of the drug delivery devices market in 2017 and the forecast for the next eight years up to 2025.
The size of the global drug delivery devices market is provided in terms of revenue in US$ Mn.
The study provides a detailed view of the drug delivery devices market, by segmenting it based on by delivery route, by product type, by End- User and regional demand.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report.
Additionally, the report includes potential opportunities in the drug delivery devices market at the global and regional levels.
Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market.
